Interaction between Cu and Ag free ions and central metals in complexes with XHn units (X = B, Si, N, O, C, Al, Zn, Mg; n = 1, 2)

Recent Trends in Group 11 Hydrogen Bonding

Conventional hydrogen bonding (H-bonding) has been extensively studied in organic and biological systems. However, its role in transition metal chemistry, particularly with Group 11 metals (i. e. Cu, Ag, Au) as hydrogen bond acceptors, remains relatively unexplored. Through a combination of experimental techniques, such as Nuclear Magnetic Resonance (NMR), Infrared spectroscopy (IR), X-Ray Diffraction (XRD), and computational calculations, several aspects of H-bonding interactions with Group 11 metals are examined, shedding light on its impact on structural motifs and reactivity. These include bond strengths, geometries, and effects on electronic structures. Understanding the intricacies of hydrogen bonding within transition metal chemistry holds promise for various applications, including catalytic transformations, the construction of molecular assemblies, synthesis of complexes displaying anticancer activities, or luminescence applications (e. g. Thermally Activated Delayed Fluorescence, TADF). This review encompasses the most significant recent advances, challenges, and future prospects in this emerging field.

Electrospray Ionization Tandem Mass Spectrometry and DFT Survey of Copper(I) Ate Complexes Containing Coordinated Borohydride Anions

Copper(I) borohydride ate complexes of the type Cat⁺[XCu(BH₄)]^- have been previously postulated as intermediates in the reactions of copper salts with borohydride. Negative ion electrospray ionization of an acetonitrile solution of copper(I) phenylacetylide with a 10-fold excess of sodium borohydride (NaBH₄) revealed the formation of a diverse range of mononuclear, dinuclear and trinuclear cuprates with different numbers of BH₄^-, H^- and CN^- ligands, the latter likely being formed by abstraction of CN^- from the acetonitrile solvent. Collision-induced dissociation was used to examine the fragmentation reactions of the following borohydride containing cuprates: [Cu(H)(BH₄)]^-, [Cu(BH₄)₂]^-, [Cu(BH₄)(CN)]^-, [Cu₂(H)(BH₄)₂]^-, [Cu₂(H)₂(BH₄)]^-, [Cu₂(BH₄)₂(CN)]^-, [Cu₂(H)(BH₄)(CN)]^-, [Cu₃(H)(BH₄)₃]^-, [Cu₃(H)₂(BH₄)₂]^-, [Cu₃(H)₃(BH₄)]^-, [Cu₃(BH₄)₂(CN)₂]^-, and [Cu₃(H)(BH₄)₂(CN)]^-. In all cases, BH₃ loss is observed. For many of the dinuclear and trinuclear complexes cluster fragmentation by loss of CuH was also observed. In the case of [Cu₂(H)₂(BH₄)]^- and [Cu₃(H)₃(BH₄)]^-, loss of H₂ was also observed. DFT calculations were used to explore potential structures of the various borohydride-containing cuprates and to predict the overall reaction energetics for the various fragmentation channels.

Metal Centers as Nucleophiles: Oxymoron of Halogen Bond-Involving Crystal Engineering

This review highlights recent studies discovering unconventional halogen bonding (HaB) that involves positively charged metal centers. These centers provide their filled d‐orbitals for HaB, and thus behave as nucleophilic components toward the noncovalent interaction. This role of some electron‐rich transition metal centers can be considered an oxymoron in the sense that the metal is, in most cases, formally cationic; consequently, its electron donor function is unexpected. The importance of Ha⋅⋅⋅d‐[M] (Ha=halogen; M is Group 9 (Rh, Ir), 10 (Ni, Pd, Pt), or 11 (Cu, Au)) interactions in crystal engineering is emphasized by showing remarkable examples (reported and uncovered by our processing of the Cambridge Structural Database), where this Ha⋅⋅⋅d‐[M] directional interaction guides the formation of solid supramolecular assemblies of different dimensionalities.

Targeted Delivery of Colloidal Silver for MCF-7 Breast Cancer Treatment

BACKGROUND

Amongst various cancer diseases, breast cancer is frequently diagnosed malignancy in women. Existing treatments are inadequate, painful and toxic. New ways of treatments need to be explored.

METHODS

The present work proposes preparation and targeted delivery of a formulation, F-1, for MCF-7 breast cancer treatment. The formulation, colloidal silver (0.76 ppm), was prepared by electrolytic deposition technique and multi surface coatings. Black tea extract (2.25%v/v) was used as a capping agent to tune the morphology of silver nanoparticle and potato extract (6.25%v/v) as a functionalizing agent for targeting MCF-7 breast cancer site.

RESULTS

Characterization results show highly pure spherical silver nanoparticles with an average particle size of 15nm. The shift of peaks in the FTIR spectra of formulation confirms the interaction between nanoparticles and extracts. The UV-visible peak was obtained at 525nm, a typical characteristic of silver nanoparticles. In-vivo; anti-cancer study of formulation gave a moderate therapeutic effect in Non-Obese Diabetic Severe Combined Immune Deficiency (NOD-SCID) mice.

CONCLUSION

It is observed that tumor volumes obtained in the case of Formulation-1 were moderately inhibited from days 5 to 9. However, one of the mice in the Formulation-1 group inhibited tumor volume to 1.52 cc similar to one of the mice of positive control group (Adriamycin 1.42cc).